emka TECHNOLOGIES KK is a fully owned Japanese subsidiary of emka TECHNOLOGIES, SAS Paris France. As the Japanese subsidiary emka TECHNOLOGIES KK sells and services the innovative products and services for preclinical in vivo and in vitro research developed for over the past 20 years by emka TECHNOLOGIES SAS and SCIREQ. Our hardware and software are used daily in toxicology and safety pharmacology studies, validated by major pharma companies and CROs, globally and in Japan. Our solutions are cited in over 1,100 peer-reviewed scientific publications. To meet the 3R's requirements, we offer: * in vitro hardware, to replace whole animal models (tissue/organ bath benchtop, perfused isolated heart setups, amplifiers, stimulators, transducers...) * telemetry hardware, a wireless technique designed to offer a wide range of parameters (ECG, blood pressure, respiration, temperature, acceleration) from unrestrained animals, thus insuring the animal comfort and welfare while maximizing experimental data integrity.